Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics
The vulnerable plaques in atherosclerosis can cause severe outcome with great danger of acute cardiovascular events. Thus, timely diagnosis and treatment of vulnerable plaques in early stage can effectively benefit the clinical management of atherosclerosis. In this work, a targeting theranostic str...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2024-07-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X24001002 |
| _version_ | 1827198288945741824 |
|---|---|
| author | Yao Wang Zhebin Chen Qiongjun Zhu Zhezhe Chen Guosheng Fu Boxuan Ma Wenbin Zhang |
| author_facet | Yao Wang Zhebin Chen Qiongjun Zhu Zhezhe Chen Guosheng Fu Boxuan Ma Wenbin Zhang |
| author_sort | Yao Wang |
| collection | DOAJ |
| description | The vulnerable plaques in atherosclerosis can cause severe outcome with great danger of acute cardiovascular events. Thus, timely diagnosis and treatment of vulnerable plaques in early stage can effectively benefit the clinical management of atherosclerosis. In this work, a targeting theranostic strategy on early-stage vulnerable plaques in atherosclerosis is realized by a LAID nanoplatform with X-CT and fluorescent dual-mode imaging and lipid-inflammation integrated regulation abilities. The iodinated contrast agents (ICA), phenylboronic acid modified astaxanthin and oxidized-dextran (oxDEX) jointly construct the nanoparticles loaded with the lipid-specific probe LFP. LAID indicates an active targeting to plaques along with the dual-responsive disassembly in oxidative stress and acidic microenvironment of atherosclerosis. The X-CT signals of ICA execute the location of early-stage plaques, while the LFP combines with lipid cores and realizes the recognition of vulnerable plaques. Meanwhile, the treatment based on astaxanthin is performed for restraining the progression of plaques. Transcriptome sequencing suggests that LAID can inhibit the lipid uptake and block NF-κB pathway, which synergistically demonstrates a lipid-inflammation integrated regulation to suppression the plaques growing. The in vivo investigations suggest that LAID delivers a favorable theranostics to the early-stage vulnerable plaques, which provides an impressive prospect for reducing the adverse prognosis of atherosclerosis. |
| first_indexed | 2024-04-24T22:56:45Z |
| format | Article |
| id | doaj.art-230837071a8a40739f7ce105d0151f1d |
| institution | Directory Open Access Journal |
| issn | 2452-199X |
| language | English |
| last_indexed | 2025-03-21T10:14:39Z |
| publishDate | 2024-07-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Bioactive Materials |
| spelling | doaj.art-230837071a8a40739f7ce105d0151f1d2024-07-04T04:14:57ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2024-07-013794105Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranosticsYao Wang0Zhebin Chen1Qiongjun Zhu2Zhezhe Chen3Guosheng Fu4Boxuan Ma5Wenbin Zhang6Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, ChinaDepartment of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China; Corresponding author. Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China; Corresponding author. Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China; Corresponding author. Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.The vulnerable plaques in atherosclerosis can cause severe outcome with great danger of acute cardiovascular events. Thus, timely diagnosis and treatment of vulnerable plaques in early stage can effectively benefit the clinical management of atherosclerosis. In this work, a targeting theranostic strategy on early-stage vulnerable plaques in atherosclerosis is realized by a LAID nanoplatform with X-CT and fluorescent dual-mode imaging and lipid-inflammation integrated regulation abilities. The iodinated contrast agents (ICA), phenylboronic acid modified astaxanthin and oxidized-dextran (oxDEX) jointly construct the nanoparticles loaded with the lipid-specific probe LFP. LAID indicates an active targeting to plaques along with the dual-responsive disassembly in oxidative stress and acidic microenvironment of atherosclerosis. The X-CT signals of ICA execute the location of early-stage plaques, while the LFP combines with lipid cores and realizes the recognition of vulnerable plaques. Meanwhile, the treatment based on astaxanthin is performed for restraining the progression of plaques. Transcriptome sequencing suggests that LAID can inhibit the lipid uptake and block NF-κB pathway, which synergistically demonstrates a lipid-inflammation integrated regulation to suppression the plaques growing. The in vivo investigations suggest that LAID delivers a favorable theranostics to the early-stage vulnerable plaques, which provides an impressive prospect for reducing the adverse prognosis of atherosclerosis.http://www.sciencedirect.com/science/article/pii/S2452199X24001002AtherosclerosisTheranosticsNanoplatformDual-mode imagingLipid-inflammation integrated regulation |
| spellingShingle | Yao Wang Zhebin Chen Qiongjun Zhu Zhezhe Chen Guosheng Fu Boxuan Ma Wenbin Zhang Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics Bioactive Materials Atherosclerosis Theranostics Nanoplatform Dual-mode imaging Lipid-inflammation integrated regulation |
| title | Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics |
| title_full | Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics |
| title_fullStr | Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics |
| title_full_unstemmed | Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics |
| title_short | Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics |
| title_sort | aiming at early stage vulnerable plaques a nanoplatform with dual mode imaging and lipid inflammation integrated regulation for atherosclerotic theranostics |
| topic | Atherosclerosis Theranostics Nanoplatform Dual-mode imaging Lipid-inflammation integrated regulation |
| url | http://www.sciencedirect.com/science/article/pii/S2452199X24001002 |
| work_keys_str_mv | AT yaowang aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT zhebinchen aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT qiongjunzhu aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT zhezhechen aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT guoshengfu aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT boxuanma aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics AT wenbinzhang aimingatearlystagevulnerableplaquesananoplatformwithdualmodeimagingandlipidinflammationintegratedregulationforatherosclerotictheranostics |